Back to medications
Medication monograph

ocrelizumab

Anti-CD20 Monoclonal AntibodiesNeurologicsMultiple Sclerosis TreatmentsCD20-directed Cytolytic AntibodyImmunomodulatory AgentsImmunomodulatory Agents

Clinical reference

Product monograph

OCREVUS- ocrelizumab injection

Brands & formulations

Family members

OCREVUS

Marketed
30 MGINTRAVENOUSSOLUTION[ "ocrelizumab" ]
Product monograph

Classification

Chemical class
Anti-CD20 Monoclonal Antibodies
Clinical class
Neurologics, Multiple Sclerosis Treatments
Banks class
CD20-directed Cytolytic Antibody, Immunomodulatory Agents
AHFS family
Immunomodulatory Agents